Tweet
Today's press release indicates they are fully enrolled for Phase III clinicals for Nova22007 - however this is for use in treating vernal keratoconjunctivitis (severe chronic allergic conjunctivitis) not dry eye. They expect to soon initiate Phase III clinicals in Europe and US for dry eye.
Press release here
This and other clinical trial updates are updated as they happen in The Dry Eye Digest. As always... anything we miss or get wrong, let us know please so we can keep it complete and up to date!
Press release here
This and other clinical trial updates are updated as they happen in The Dry Eye Digest. As always... anything we miss or get wrong, let us know please so we can keep it complete and up to date!